For example, miR-346 may promote docetaxel (Doc) resistance in breast cancer cells by downregulating SRCIN1 (7), and miR-3646 causes Doc resistance in human breast cancer cells via the Wnt signaling pathway (8). Here, SRCIN1 is linked to breast carcinoma.